Skip to search formSkip to main contentSkip to account menu

Vaccines, Peptide

Known as: Peptide Vaccine, Peptide Vaccines 
A vaccine based on a synthetic peptide or peptides produced from tissue samples or recombinant sources. Vaccination with peptide vaccines may elicit… 
National Institutes of Health

Related topics

Related topics

4 relations
Antigen SensitizationVaccines, Synthetic

Broader (1)

Vaccines, Subunit

Narrower (1)

dendritic cell-CEA peptide vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Biomarkers for the early diagnosis of hepatocellular carcinoma.
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading cause of cancer-related deaths worldwide… 
Review
2014
Review
2014
Peptide Vaccine: Progress and Challenges
Conventional vaccine strategies have been highly efficacious for several decades in reducing mortality and morbidity due to… 
Highly Cited
2014
Highly Cited
2014
Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens
The immune system influences the fate of developing cancers by not only functioning as a tumour promoter that facilitates… 
Highly Cited
2010
Highly Cited
2010
Improved survival with ipilimumab in patients with metastatic melanoma.
BACKGROUND An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3… 
Review
2008
Review
2008
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
This Review deals with recent progress in the immunotherapy of established (pre)malignant disease of viral or non-viral origin by… 
Highly Cited
2006
Highly Cited
2006
Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network
B‐cell epitopes play a vital role in the development of peptide vaccines, in diagnosis of diseases, and also for allergy research… 
Highly Cited
2004
Highly Cited
2004
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.
The Wilms' tumor gene WT1 is overexpressed in leukemias and various types of solid tumors, and the WT1 protein was demonstrated… 
Highly Cited
2001
Highly Cited
2001
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients.
CD4 T-cell help is required during the generation and maintenance of effective antitumor CD8 T cell-mediated immunity. The goal… 
Highly Cited
1999
Highly Cited
1999
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
The outcome of antigen recognition by naive CD8+ cytotoxic T lymphocytes (CTLs) in the periphery is orchestrated by CD4+ T-helper… 
Highly Cited
1998
Highly Cited
1998
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
The cloning of the genes encoding cancer antigens has opened new possibilities for the treatment of patients with cancer. In this… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)